The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Dry Eye Disease-Global Market Insights and Sales Trends 2024

Dry Eye Disease-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1860248

No of Pages : 113

Ask Your Query
Synopsis
Dry eye disease is a multifactorial disease which is characterized by insufficiency of tears in eye. Insufficient lubrication in eye lead to burning, sensing, redness and pain in eye.
The global Dry Eye Disease market size is expected to reach US$ 2949.6 million by 2029, growing at a CAGR of 2.6% from 2023 to 2029. The market is mainly driven by the significant applications of Dry Eye Disease in various end use industries. The expanding demands from the Hospital, Drug Stores and Online Pharmacies,, are propelling Dry Eye Disease market. Artificial Tears, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Anti-inflammatory Drugs segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Dry Eye Disease market, driven by demand from China, the second largest economy with some signs of stabilising, the Dry Eye Disease market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dry Eye Disease, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Dry Eye Disease market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dry Eye Disease market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dry Eye Disease sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dry Eye Disease covered in this report include Santen Pharma, Novartis, Llergan, Takeda, TRB Chemedica, Sun Pharmaceutical, Senju Pharmaceutical, Sentiss Pharma and Johnson & Johnson, etc.
The global Dry Eye Disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Santen Pharma
Novartis
Llergan
Takeda
TRB Chemedica
Sun Pharmaceutical
Senju Pharmaceutical
Sentiss Pharma
Johnson & Johnson
Otsuka
Mitotech
FCI
Altacor
Valeant Pharmaceuticals
United Laboratories
Jianfeng Group
Eusan GMBH
Global Dry Eye Disease market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dry Eye Disease market, Segment by Type:
Artificial Tears
Anti-inflammatory Drugs
Other
Global Dry Eye Disease market, by Application
Hospital
Drug Stores
Online Pharmacies
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Dry Eye Disease manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Dry Eye Disease in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Dry Eye Disease Market Overview
1.1 Dry Eye Disease Product Overview
1.2 Dry Eye Disease Market Segment by Type
1.2.1 Artificial Tears
1.2.2 Anti-inflammatory Drugs
1.2.3 Other
1.3 Global Dry Eye Disease Market Size by Type
1.3.1 Global Dry Eye Disease Market Size Overview by Type (2018-2029)
1.3.2 Global Dry Eye Disease Historic Market Size Review by Type (2018-2023)
1.3.3 Global Dry Eye Disease Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Dry Eye Disease Sales Breakdown by Type (2018-2023)
1.4.2 Europe Dry Eye Disease Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Dry Eye Disease Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Dry Eye Disease Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Dry Eye Disease Sales Breakdown by Type (2018-2023)
2 Global Dry Eye Disease Market Competition by Company
2.1 Global Top Players by Dry Eye Disease Sales (2018-2023)
2.2 Global Top Players by Dry Eye Disease Revenue (2018-2023)
2.3 Global Top Players by Dry Eye Disease Price (2018-2023)
2.4 Global Top Manufacturers Dry Eye Disease Manufacturing Base Distribution, Sales Area, Product Type
2.5 Dry Eye Disease Market Competitive Situation and Trends
2.5.1 Dry Eye Disease Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Dry Eye Disease Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dry Eye Disease as of 2022)
2.7 Date of Key Manufacturers Enter into Dry Eye Disease Market
2.8 Key Manufacturers Dry Eye Disease Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Dry Eye Disease Status and Outlook by Region
3.1 Global Dry Eye Disease Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Dry Eye Disease Historic Market Size by Region
3.2.1 Global Dry Eye Disease Sales in Volume by Region (2018-2023)
3.2.2 Global Dry Eye Disease Sales in Value by Region (2018-2023)
3.2.3 Global Dry Eye Disease Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Dry Eye Disease Forecasted Market Size by Region
3.3.1 Global Dry Eye Disease Sales in Volume by Region (2024-2029)
3.3.2 Global Dry Eye Disease Sales in Value by Region (2024-2029)
3.3.3 Global Dry Eye Disease Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Dry Eye Disease by Application
4.1 Dry Eye Disease Market Segment by Application
4.1.1 Hospital
4.1.2 Drug Stores
4.1.3 Online Pharmacies
4.2 Global Dry Eye Disease Market Size by Application
4.2.1 Global Dry Eye Disease Market Size Overview by Application (2018-2029)
4.2.2 Global Dry Eye Disease Historic Market Size Review by Application (2018-2023)
4.2.3 Global Dry Eye Disease Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Dry Eye Disease Sales Breakdown by Application (2018-2023)
4.3.2 Europe Dry Eye Disease Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Dry Eye Disease Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Dry Eye Disease Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Dry Eye Disease Sales Breakdown by Application (2018-2023)
5 North America Dry Eye Disease by Country
5.1 North America Dry Eye Disease Historic Market Size by Country
5.1.1 North America Dry Eye Disease Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Dry Eye Disease Sales in Volume by Country (2018-2023)
5.1.3 North America Dry Eye Disease Sales in Value by Country (2018-2023)
5.2 North America Dry Eye Disease Forecasted Market Size by Country
5.2.1 North America Dry Eye Disease Sales in Volume by Country (2024-2029)
5.2.2 North America Dry Eye Disease Sales in Value by Country (2024-2029)
6 Europe Dry Eye Disease by Country
6.1 Europe Dry Eye Disease Historic Market Size by Country
6.1.1 Europe Dry Eye Disease Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Dry Eye Disease Sales in Volume by Country (2018-2023)
6.1.3 Europe Dry Eye Disease Sales in Value by Country (2018-2023)
6.2 Europe Dry Eye Disease Forecasted Market Size by Country
6.2.1 Europe Dry Eye Disease Sales in Volume by Country (2024-2029)
6.2.2 Europe Dry Eye Disease Sales in Value by Country (2024-2029)
7 Asia-Pacific Dry Eye Disease by Region
7.1 Asia-Pacific Dry Eye Disease Historic Market Size by Region
7.1.1 Asia-Pacific Dry Eye Disease Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Dry Eye Disease Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Dry Eye Disease Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Dry Eye Disease Forecasted Market Size by Region
7.2.1 Asia-Pacific Dry Eye Disease Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Dry Eye Disease Sales in Value by Region (2024-2029)
8 Latin America Dry Eye Disease by Country
8.1 Latin America Dry Eye Disease Historic Market Size by Country
8.1.1 Latin America Dry Eye Disease Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Dry Eye Disease Sales in Volume by Country (2018-2023)
8.1.3 Latin America Dry Eye Disease Sales in Value by Country (2018-2023)
8.2 Latin America Dry Eye Disease Forecasted Market Size by Country
8.2.1 Latin America Dry Eye Disease Sales in Volume by Country (2024-2029)
8.2.2 Latin America Dry Eye Disease Sales in Value by Country (2024-2029)
9 Middle East and Africa Dry Eye Disease by Country
9.1 Middle East and Africa Dry Eye Disease Historic Market Size by Country
9.1.1 Middle East and Africa Dry Eye Disease Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Dry Eye Disease Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Dry Eye Disease Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Dry Eye Disease Forecasted Market Size by Country
9.2.1 Middle East and Africa Dry Eye Disease Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Dry Eye Disease Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Santen Pharma
10.1.1 Santen Pharma Company Information
10.1.2 Santen Pharma Introduction and Business Overview
10.1.3 Santen Pharma Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Santen Pharma Dry Eye Disease Products Offered
10.1.5 Santen Pharma Recent Development
10.2 Novartis
10.2.1 Novartis Company Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novartis Dry Eye Disease Products Offered
10.2.5 Novartis Recent Development
10.3 Llergan
10.3.1 Llergan Company Information
10.3.2 Llergan Introduction and Business Overview
10.3.3 Llergan Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Llergan Dry Eye Disease Products Offered
10.3.5 Llergan Recent Development
10.4 Takeda
10.4.1 Takeda Company Information
10.4.2 Takeda Introduction and Business Overview
10.4.3 Takeda Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Takeda Dry Eye Disease Products Offered
10.4.5 Takeda Recent Development
10.5 TRB Chemedica
10.5.1 TRB Chemedica Company Information
10.5.2 TRB Chemedica Introduction and Business Overview
10.5.3 TRB Chemedica Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
10.5.4 TRB Chemedica Dry Eye Disease Products Offered
10.5.5 TRB Chemedica Recent Development
10.6 Sun Pharmaceutical
10.6.1 Sun Pharmaceutical Company Information
10.6.2 Sun Pharmaceutical Introduction and Business Overview
10.6.3 Sun Pharmaceutical Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sun Pharmaceutical Dry Eye Disease Products Offered
10.6.5 Sun Pharmaceutical Recent Development
10.7 Senju Pharmaceutical
10.7.1 Senju Pharmaceutical Company Information
10.7.2 Senju Pharmaceutical Introduction and Business Overview
10.7.3 Senju Pharmaceutical Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Senju Pharmaceutical Dry Eye Disease Products Offered
10.7.5 Senju Pharmaceutical Recent Development
10.8 Sentiss Pharma
10.8.1 Sentiss Pharma Company Information
10.8.2 Sentiss Pharma Introduction and Business Overview
10.8.3 Sentiss Pharma Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sentiss Pharma Dry Eye Disease Products Offered
10.8.5 Sentiss Pharma Recent Development
10.9 Johnson & Johnson
10.9.1 Johnson & Johnson Company Information
10.9.2 Johnson & Johnson Introduction and Business Overview
10.9.3 Johnson & Johnson Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Johnson & Johnson Dry Eye Disease Products Offered
10.9.5 Johnson & Johnson Recent Development
10.10 Otsuka
10.10.1 Otsuka Company Information
10.10.2 Otsuka Introduction and Business Overview
10.10.3 Otsuka Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Otsuka Dry Eye Disease Products Offered
10.10.5 Otsuka Recent Development
10.11 Mitotech
10.11.1 Mitotech Company Information
10.11.2 Mitotech Introduction and Business Overview
10.11.3 Mitotech Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Mitotech Dry Eye Disease Products Offered
10.11.5 Mitotech Recent Development
10.12 FCI
10.12.1 FCI Company Information
10.12.2 FCI Introduction and Business Overview
10.12.3 FCI Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
10.12.4 FCI Dry Eye Disease Products Offered
10.12.5 FCI Recent Development
10.13 Altacor
10.13.1 Altacor Company Information
10.13.2 Altacor Introduction and Business Overview
10.13.3 Altacor Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Altacor Dry Eye Disease Products Offered
10.13.5 Altacor Recent Development
10.14 Valeant Pharmaceuticals
10.14.1 Valeant Pharmaceuticals Company Information
10.14.2 Valeant Pharmaceuticals Introduction and Business Overview
10.14.3 Valeant Pharmaceuticals Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Valeant Pharmaceuticals Dry Eye Disease Products Offered
10.14.5 Valeant Pharmaceuticals Recent Development
10.15 United Laboratories
10.15.1 United Laboratories Company Information
10.15.2 United Laboratories Introduction and Business Overview
10.15.3 United Laboratories Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
10.15.4 United Laboratories Dry Eye Disease Products Offered
10.15.5 United Laboratories Recent Development
10.16 Jianfeng Group
10.16.1 Jianfeng Group Company Information
10.16.2 Jianfeng Group Introduction and Business Overview
10.16.3 Jianfeng Group Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Jianfeng Group Dry Eye Disease Products Offered
10.16.5 Jianfeng Group Recent Development
10.17 Eusan GMBH
10.17.1 Eusan GMBH Company Information
10.17.2 Eusan GMBH Introduction and Business Overview
10.17.3 Eusan GMBH Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Eusan GMBH Dry Eye Disease Products Offered
10.17.5 Eusan GMBH Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Dry Eye Disease Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Dry Eye Disease Industrial Chain Analysis
11.4 Dry Eye Disease Market Dynamics
11.4.1 Dry Eye Disease Industry Trends
11.4.2 Dry Eye Disease Market Drivers
11.4.3 Dry Eye Disease Market Challenges
11.4.4 Dry Eye Disease Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Dry Eye Disease Distributors
12.3 Dry Eye Disease Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock